You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 2, February 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Adrenal Size Is Increased in Multiple Sclerosis

Anthony T. Reder, MD; Richard L. Makowiec; Martin T. Lowy, PhD

Arch Neurol. 1994;51(2):151-154.


Abstract

Objective
To determine if adrenal glands are enlarged in multiple sclerosis (MS). Patients with MS and major depression are insensitive to glucocorticoid feedback regulation. Depressed patients have excessively high glucocorticoid levels and enlarged adrenal glands. To our knowledge, this is the first study of adrenal size in MS. Chronic high levels of adrenal glucocorticoid in MS may downregulate responses to exogenous or endogenous steroids.

Design
Retrospective postmortem analysis compared adrenal size in MS with that in other neurologic and non-neurologic diseases.

Setting
Autopsy cases were obtained from the records of a tertiary care hospital.

Patients
Ten patients had definite MS; 13, amyotrophic lateral sclerosis; and 14, acute myocardial infarction.

Main Outcome Measures
Adrenal and body weight at autopsy.

Results
At postmortem examination, the adrenal glands of patients with MS were enlarged in comparison with the adrenal glands of patients who died of acute myocardial infarction or amyotrophic lateral sclerosis. The adrenal glands of the patients with MS were 36% larger than those of the patients with amyotrophic lateral sclerosis who had comparable body weights. The adrenal-body weight ratio was 40% greater in patients with MS than in patients who died of acute myocardial infarction.

Conclusions
The increased adrenal size in patients with MS may allow excessive glucocorticoid secretion in response to stress and affect immune regulation.



Author Affiliations

From the Department of Neurology, University of Chicago (Ill) and the Brain Research Institute (Dr Reder), and the University of Illinois at Chicago, School of Medicine (Mr Makowiec); and the Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio (Dr Lowy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis
Ysrraelit et al.
Neurology 2008;71:1948-1954.
ABSTRACT | FULL TEXT  

Review: Brain immune communication psychoneuroimmunology of multiple sclerosis
Kern and Ziemssen
Mult Scler 2008;14:6-21.
ABSTRACT  

The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group
Mult Scler 2005;11:328-337.
ABSTRACT  

Corticotropin-Releasing Hormone Contributes to the Peripheral Inflammatory Response in Experimental Autoimmune Encephalomyelitis
Benou et al.
J. Immunol. 2005;174:5407-5413.
ABSTRACT | FULL TEXT  

Sensitivity to Glucocorticoids Is Decreased in Relapsing Remitting Multiple Sclerosis
van Winsen et al.
J. Clin. Endocrinol. Metab. 2005;90:734-740.
ABSTRACT | FULL TEXT  

Further evidence that mammalian sex ratios at birth are partially controlled by parental hormone levels around the time of conception
James
Hum Reprod 2004;19:1250-1256.
ABSTRACT | FULL TEXT  

Combined Treatment with Corticosteroids and Moclobemide Favors Normalization of Hypothalamo-Pituitary-Adrenal Axis Dysregulation in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double Blind Trial
Bergh et al.
J. Clin. Endocrinol. Metab. 2001;86:1610-1615.
ABSTRACT | FULL TEXT  

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS
Bergh et al.
Neurology 1999;53:772-772.
ABSTRACT | FULL TEXT  

Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1
Del Rey et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 1998;275:R1146-R1151.
ABSTRACT | FULL TEXT  

Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis: Association With Cerebral Inflammation
Fassbender et al.
Arch Neurol 1998;55:66-72.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.